Misoprostol 50 microg sublingually versus vaginally for labor induction at term: a randomized study.

Area of Science:

• Obstetrics and Gynecology
• Pharmacology

Background:

• Labor induction is a common obstetric procedure.
• Misoprostol is widely used for labor induction.
• Different routes of administration may affect efficacy and safety.

Purpose of the Study:

• To compare the efficacy and safety of vaginal versus sublingual misoprostol for labor induction at term.
• To evaluate key outcomes including cesarean delivery rates, induction-to-delivery time, and neonatal well-being.

Main Methods:

• A randomized controlled trial involving 160 women at term.
• Participants received either 50 mcg of misoprostol vaginally or 50 mcg sublingually every 4 hours (maximum 6 doses).
• Primary outcome was cesarean delivery; secondary outcomes included induction-to-delivery interval, delivery within 24 hours, doses required, oxytocin augmentation, tachysystole, and neonatal outcomes.

Main Results:

• No significant difference in induction-to-delivery time (748 min vaginal vs. 711 min sublingual) or delivery within 24 hours (91.3% vaginal vs. 92.5% sublingual).
• Significantly more doses were required with sublingual administration (1.9 vs. 1.1; p < 0.001).
• Higher rates of tachysystole were observed with sublingual misoprostol (17.5% vs. 3.8%; p = 0.005), but cesarean delivery for fetal distress and neonatal outcomes were similar between groups.

Conclusions:

• Sublingual misoprostol is an effective alternative to vaginal misoprostol for labor induction.
• Increased monitoring for tachysystole is warranted with sublingual administration.
• Neonatal outcomes remain comparable regardless of administration route.